Literature DB >> 33289330

Analysis of differentially expressed genes in oral epithelial cells infected with Fusobacterium nucleatum for revealing genes associated with oral cancer.

Shuwei Zhang1, Chen Li1, Zhiying Zhang1, Yuchao Li1, Qian Li2, Fengxue Geng1, Junchao Liu1, Yaping Pan1,2.   

Abstract

Accumulating evidence links Fusobacterium nucleatum with tumorigenesis. Our previous study demonstrated that F. nucleatum infection can induce epithelial-mesenchymal transition (EMT) in oral epithelial cells and elaborated a probable signal pathway involved in the induction of EMT. However, the comprehensive profiling and pathways of other candidate genes involved in F. nucleatum promoting malignant transformation remain largely elusive. Here, we analysed the transcriptome profile of HIOECs exposed to F. nucleatum infection. Totally, 3307 mRNAs (ǀLog2FCǀ >1.5) and 522 lncRNAs (ǀLog2FCǀ >1) were identified to be differentially expressed in F. nucleatum-infected HIOECs compared with non-infected HIOECs. GO and KEGG pathway analyses were performed to investigate the potential functions of the dysregulated genes. Tumour-associated genes were integrated, and top 10 hub genes (FYN, RAF1, ATM, FOS, CREB, NCOA3, VEGFA, JAK2, CREM and ATF3) were identified by protein-protein interaction (PPI) network, and Oncomine was used to validate hub genes' expression. LncRNA-hub genes co-expression network comprising 67 dysregulated lncRNAs were generated. Together, our study revealed the alteration of lncRNA and potential hub genes in oral epithelial cells in response to F. nucleatum infection, which may provide new insights into the shift of normal to malignant transformation initiated by oral bacterial infection.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Fusobacterium nucleatumzzm321990; TAGs; high-throughput sequencing; lncRNA; malignant transformation

Mesh:

Substances:

Year:  2020        PMID: 33289330      PMCID: PMC7812288          DOI: 10.1111/jcmm.16142

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


  61 in total

Review 1.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

2.  Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma.

Authors:  Kensuke Yamamura; Daisuke Izumi; Raju Kandimalla; Fuminori Sonohara; Yoshifumi Baba; Naoya Yoshida; Yasuhiro Kodera; Hideo Baba; Ajay Goel
Journal:  Clin Cancer Res       Date:  2019-07-29       Impact factor: 12.531

3.  Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis.

Authors:  Christian Gethings-Behncke; Helen G Coleman; Haydee W T Jordao; Daniel B Longley; Nyree Crawford; Liam J Murray; Andrew T Kunzmann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-01-08       Impact factor: 4.254

4.  LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.

Authors:  Kai Yan; Jie Tian; Wenzheng Shi; Hao Xia; Yuanfang Zhu
Journal:  Cell Physiol Biochem       Date:  2017-06-27

5.  lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial-mesenchymal transition by competitively binding miR-141-3p.

Authors:  Weibin Qian; Xinrui Cai; Qiuhai Qian; Wei Peng; Jie Yu; Xinying Zhang; Li Tian; Can Wang
Journal:  Cell Death Dis       Date:  2019-02-12       Impact factor: 8.469

6.  LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.

Authors:  Xiaoliu Du; Yiming Tu; Shuang Liu; Pengzhan Zhao; Zhongyuan Bao; Chong Li; Jinhao Li; Minhong Pan; Jing Ji
Journal:  J Cell Mol Med       Date:  2019-12-19       Impact factor: 5.310

7.  Fusobacterium nucleatum Facilitates Apoptosis, ROS Generation, and Inflammatory Cytokine Production by Activating AKT/MAPK and NF-κB Signaling Pathways in Human Gingival Fibroblasts.

Authors:  Wenyan Kang; Zhilong Jia; Di Tang; Zhanwei Zhang; Hui Gao; Kunlun He; Qiang Feng
Journal:  Oxid Med Cell Longev       Date:  2019-10-13       Impact factor: 6.543

8.  Fusobacterium nucleatum Caused DNA Damage and Promoted Cell Proliferation by the Ku70/p53 Pathway in Oral Cancer Cells.

Authors:  Fengxue Geng; Yunjia Zhang; Ze Lu; Shuwei Zhang; Yaping Pan
Journal:  DNA Cell Biol       Date:  2019-11-25       Impact factor: 3.311

9.  lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.

Authors:  Yan Gao; Yongchuan Xu; Jue Wang; Xue Yang; Lulu Wen; Juan Feng
Journal:  Oncol Res       Date:  2018-04-20       Impact factor: 5.574

10.  AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation.

Authors:  Miao Wang; Feng Zhao; Shujing Li; Alan K Chang; Zhaojun Jia; Yixuan Chen; Feihong Xu; Hongming Pan; Huijian Wu
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

View more
  10 in total

1.  Comparative Analysis of Gene Expression Patterns for Oral Epithelial Cell Functions in Periodontitis.

Authors:  Octavio A Gonzalez; Sreenatha Kirakodu; Linh M Nguyen; Luis Orraca; Michael J Novak; Janis Gonzalez-Martinez; Jeffrey L Ebersole
Journal:  Front Oral Health       Date:  2022-05-23

Review 2.  Pathogenic Mechanisms of Fusobacterium nucleatum on Oral Epithelial Cells.

Authors:  Sabine Groeger; Yuxi Zhou; Sabine Ruf; Joerg Meyle
Journal:  Front Oral Health       Date:  2022-04-05

Review 3.  More Than Just a Periodontal Pathogen -the Research Progress on Fusobacterium nucleatum.

Authors:  Yuanxin Chen; Zhijie Huang; Zhengming Tang; Yisheng Huang; Mingshu Huang; Hongyu Liu; Dirk Ziebolz; Gerhard Schmalz; Bo Jia; Jianjiang Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-02-03       Impact factor: 5.293

Review 4.  Oral microbiota in human systematic diseases.

Authors:  Xian Peng; Lei Cheng; Yong You; Chengwei Tang; Biao Ren; Yuqing Li; Xin Xu; Xuedong Zhou
Journal:  Int J Oral Sci       Date:  2022-03-02       Impact factor: 24.897

Review 5.  Leaky Gum: The Revisited Origin of Systemic Diseases.

Authors:  Do-Young Park; Jin Young Park; Dahye Lee; Inseong Hwang; Hye-Sung Kim
Journal:  Cells       Date:  2022-03-23       Impact factor: 6.600

6.  Metagenomic Analysis Reveals a Changing Microbiome Associated With the Depth of Invasion of Oral Squamous Cell Carcinoma.

Authors:  Yuan Liu; Zhengrui Li; Yanxu Qi; Xutao Wen; Ling Zhang
Journal:  Front Microbiol       Date:  2022-02-09       Impact factor: 5.640

Review 7.  Involvement of Fusobacterium nucleatum in malignancies except for colorectal cancer: A literature review.

Authors:  Zhixing He; Wei Tian; Qichun Wei; Jing Xu
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

8.  Exploring the Novel Computational Drug Target and Associated Key Pathways of Oral Cancer.

Authors:  Fatema Akhter; Fawzia Haif Al Kahtani; Zainah Mohammed Sambawa; Deema Abdulrahman Alhassan; Reema Abdulaziz AlSaif; Tahsinul Haque; Mohammad Khursheed Alam; Md Tanvir Hasan; Md Rakibul Islam; Kawsar Ahmed; Rehana Basri
Journal:  Curr Issues Mol Biol       Date:  2022-08-09       Impact factor: 2.976

9.  Analysis of differentially expressed genes in oral epithelial cells infected with Fusobacterium nucleatum for revealing genes associated with oral cancer.

Authors:  Shuwei Zhang; Chen Li; Zhiying Zhang; Yuchao Li; Qian Li; Fengxue Geng; Junchao Liu; Yaping Pan
Journal:  J Cell Mol Med       Date:  2020-12-02       Impact factor: 5.295

10.  Palmitate-Triggered COX2/PGE2-Related Hyperinflammation in Dual-Stressed PdL Fibroblasts Is Mediated by Repressive H3K27 Trimethylation.

Authors:  Lisa Schuldt; Michael Reimann; Katrin von Brandenstein; Julia Steinmetz; Annika Döding; Ulrike Schulze-Späte; Collin Jacobs; Judit Symmank
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.